Altimmune, Inc. (ALT) - Latest Market Data

Price & Market Data

Price: $3.07

Daily Change: -$0.0189 / 0.62%

Daily Range: $3.01 - $3.12

Market Cap: $598,613,952

Daily Volume: 2,436,619

Performance Metrics

1 Week: 0.65%

1 Month: -4.64%

3 Months: -33.76%

6 Months: -25.06%

1 Year: -48.75%

YTD: -14.68%

About Altimmune, Inc. (ALT)

All about Altimmune, Inc. (ALT). Current price: 3.07, daily change: -$0.0189 / 0.62%. Market cap: 598,613,952. Performance 1-week, 6-month, 1-year.

Company Details

Employees: 57

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Selected stocks

BriaCell Therapeutics Corp. (BCTX)

Greenwave Technology Solutions, Inc. (GWAV)

Commercial Bancgroup, Inc. (CBK)

DigitalOcean Holdings, Inc. (DOCN)